Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Rehabilitation Combined With Bihemispherictranscranial Direct Current Stimulation in Subacute Ischemic Stroke (RECOMBINE)

18. september 2017 oppdatert av: Dr. med. Carlo Cereda

Rehabilitation Combined With Bihemispherictranscranial Direct Current Stimulation in Subacute Ischemic Stroke to Increase Upper Limb Motor Recovery, a Randomised, Controlled, Double-blind Study

Rehabilitation after stroke improves motor functions by promoting plastic changes however, after completing standard rehabilitation, 50-60% of patients still exhibit some degree of motor impairment and require at least partial assistance in activities of day living. Therefore, the exploration of other approaches to promote recovery is compulsory. Non invasive brain stimulation and motor rehabilitation are thought to share similar mechanisms in inducing neuroplastic changes in the human cortex and an emerging field of research is focusing on the possibility of coupling both therapies in order to achieve an additive effect and improve outcome.

We hypothesize that coupling bihemispheric transcranial direct current stimulation (tDCS) with simultaneous physical/occupational therapy in the subacute phase of ischemic stroke patients may improve upper limb motor recovery in humans.

This is a randomized, controlled, double blind, cross-over, multicentre, clinical trial. Thirty-six ischemic stroke patients in the subacute phase will be recruited in three centers of neurorehabilitation in Switzerland. After stratification based on the Fugl-Meyer Assessment Upper Extremity according to the severity of the deficit, the patient will be randomized to receive besides standardized physical/occupational treatment according to the Impairment-Oriented Training, tDCS of themotor cortex (1.5 mA, 30 minutes) (group 1: 12 patients) or sham stimulation (without current) (group 2: 12 patients). After three weeks of treatment group 1 and 2 will cross-over and will be treated for other three weeks. Group 3 (12 patients) will receive routine physical/occupational treatment and sham tDCS for six weeks. Assessment will be performed before starting tDCS, at week 3, 6 and at 6 months. Outcome measures are the Fugl-Meyer Assessment Upper Extremity, the extended Barthel Index, the Ashworth scale, the Test of Upper Limb Apraxia (only baseline, week 6, month6), the grip strength evaluated by the Jamar Hydraulic Hand dynamometer. At baseline at week 6 and at month 6 depression will be assessed by the Hamilton depression Rating Scale.

Studieoversikt

Studietype

Intervensjonell

Registrering (Forventet)

36

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studer Kontakt Backup

Studiesteder

      • Bern, Sveits, 3010
        • Tilbaketrukket
        • Universitätsspital Bern, Inselspital, Neuropsychologische Rehabilitation
      • Brissago, Sveits, 6614
        • Rekruttering
        • Clinica Hildebrand, Centro di riabilitazione Brissago
        • Ta kontakt med:
        • Hovedetterforsker:
          • Paolo Rossi, MD
      • Zihlschlacht, Sveits, 8588
        • Avsluttet
        • HELIOS Klinik Zihlschlacht AG, Neurologisches Rehabilitationszentrum

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  1. Ischemic lesions in the territory of middle cerebral artery subcortical or subcortical/cortical confirmed neuroimaging
  2. Inclusion must be in the sub-acute phase defined as within 2-4 weeks after stroke
  3. Persistent hemiparesis, indicated by a score of 1-3 on the motor arm item of the NIH Stroke Scale (NIHSS) (Brott et al. 1989) but wrist and finger movement is not required
  4. No UE injury or conditions that limited use prior to the stroke.
  5. The patient is >18 years old.
  6. The patient has subscribed the informed consent

Exclusion Criteria:

  1. History of epilepsy, brain tumor, major head trauma, learning disorder, severe cognitive impairment, drug or alcohol abuse, major psychiatric illness
  2. Use of medications that may lower seizure threshold (e.g., metronidazole, fluoroquinolones)
  3. Severe pain in the affected upper limb (>=8 on the shoulder item of the "joint pain during passive motion" of the Fugl-Meyer Assessment Upper Extremity)
  4. Further stroke or other significant medical complication during the study
  5. Evidence of severe leucoencephalopathy (grade IV according to the Fazeka's scale)
  6. Important aphasia that would impair the understanding and performance of the assessment scales

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Annen
  • Tildeling: Randomisert
  • Intervensjonsmodell: Crossover-oppdrag
  • Masking: Dobbelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: 1 tDCS-Sham
tDC stimulation for 3 weeks, then cross-over to sham stimulation
Anodal tDCS of the ipsilesional motor cortex and cathodal tDCS of contralesional motor cortex (1.5 mA, 30 minutes) for 15 days during three weeks, then sham stimulation for 30 seconds on 15 days during 3 weeks
Eksperimentell: 2 Sham-tDCS
Sham stimulation for 3 weeks, then cross over to tDCS stimulation
Sham stimulation for 30 seconds on 15 days during 3 weeks, then anodal tDCS of the ipsilesional motor cortex and cathodal tDCS of contralesional motor cortex (1.5 mA, 30 minutes) for 15 days during three weeks
Sham-komparator: 3 Sham-Sham
Treatment for 6 weeks daily with sham stimulation
Sham stimulation for 30 seconds on 15 days during 6 weeks

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Fugl-Meyer Assessment Upper Extremity
Tidsramme: 6 weeks
Investigator administered questionnaire
6 weeks

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Fugl-Meyer Assessment Upper Extremity
Tidsramme: 3 weeks
Investigator administered questionnaire
3 weeks
Fugl-Meyer Assessment Upper Extremity
Tidsramme: 6 months
Investigator administered questionnaire
6 months
Barthel Index
Tidsramme: 3 weeks
Investigator administered questionnaire
3 weeks
Barthel Index
Tidsramme: 6 weeks
Investigator administered questionnaire
6 weeks
Barthel Index
Tidsramme: 6 months
Investigator administered questionnaire
6 months
Ashworth scale
Tidsramme: 3 weeks
Investigator administered questionnaire
3 weeks
Ashworth scale
Tidsramme: 6 weeks
Investigator administered questionnaire
6 weeks
Ashworth scale
Tidsramme: 6 months
Investigator administered questionnaire
6 months
Test of Upper Limb Apraxia (TULIA)
Tidsramme: 6 weeks
investigator administered questionnaire
6 weeks
Test of Upper Limb Apraxia (TULIA)
Tidsramme: 6 months
investigator administered questionnaire
6 months
Grip strength
Tidsramme: 3 weeks
Jamar Hydraulic Hand dynamometer
3 weeks
Grip strength
Tidsramme: 6 weeks
Jamar Hydraulic Hand dynamometer
6 weeks
Grip strength
Tidsramme: 6 months
Jamar Hydraulic Hand dynamometer
6 months
Hamilton depression Rating scale
Tidsramme: 6 weeks
Patient administered questionnaire
6 weeks
Hamilton depression Rating scale
Tidsramme: 6 months
Patient administered questionnaire
6 months

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Carlo Cereda, MD, Ospedale Regionale di Lugano - Civico

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart

1. mars 2013

Primær fullføring (Forventet)

1. februar 2018

Studiet fullført (Forventet)

1. februar 2018

Datoer for studieregistrering

Først innsendt

17. juli 2012

Først innsendt som oppfylte QC-kriteriene

17. juli 2012

Først lagt ut (Anslag)

19. juli 2012

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

19. september 2017

Siste oppdatering sendt inn som oppfylte QC-kriteriene

18. september 2017

Sist bekreftet

1. september 2017

Mer informasjon

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Kliniske studier på transcranial direct current stimulation (tDCS)

3
Abonnere